{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:52:55Z","timestamp":1767707575544},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.expneurol.2004.05.012","type":"journal-article","created":{"date-parts":[[2004,7,6]],"date-time":"2004-07-06T15:17:14Z","timestamp":1089127034000},"page":"78-93","source":"Crossref","is-referenced-by-count":21,"title":["Sparing of behavior and basal extracellular dopamine after 6-hydroxydopamine lesions of the nigrostriatal pathway in rats exposed to a prelesion sensitizing regimen of amphetamine"],"prefix":"10.1016","volume":"189","author":[{"given":"Isabella Anna","family":"Moroz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Peci\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Schallert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.05.012_BIB1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0006-8993(90)91318-B","article-title":"Effects of l-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats","volume":"525","author":"Abercrombie","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB2","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02244092","article-title":"Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs","volume":"102","author":"Allard","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1471-4159.1994.63031021.x","article-title":"Efficacy of brain-derived neurotrophic factor and neurotrophin-3 on neurochemical and behavioral deficits associated with partial nigrostriatal dopamine lesions","volume":"63","author":"Altar","year":"1994","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB4","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0306-4522(97)00323-0","article-title":"Acute intermittent nicotine treatment produces regional increases of basic fibroblast growth factor messenger RNA and protein in the tel- and diencephalon of the rat","volume":"83","author":"Belluardo","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB79","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1523\/JNEUROSCI.23-35-10999.2003","article-title":"Enriched environment confers resistance to phenyl-1,2,3,6-Tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors","volume":"23","author":"Bezard","year":"2003","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0306-4522(95)00364-O","article-title":"Chronic continuous infusion of (\u2212) nicotine reduces basic fibroblast growth factor messenger RNA levels in the ventral midbrain of the intact but not of the 6-hydroxydopamine-lesioned rat","volume":"70","author":"Blum","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00229549","article-title":"6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotorphic factor","volume":"111","author":"Bowenkamp","year":"1996","journal-title":"Expl. Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0306-4522(94)00524-9","article-title":"Evidence of complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine","volume":"65","author":"Cador","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0006-8993(91)90835-J","article-title":"Partial lesions of the substantia nigra: relation between extent of lesion and rotational behavior","volume":"533","author":"Carman","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB8","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1523\/JNEUROSCI.10-06-01847.1990","article-title":"Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size","volume":"10","author":"Castaneda","year":"1990","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1006\/exnr.1998.6887","article-title":"Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor","volume":"154","author":"Choi-Lundberg","year":"1998","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1476-5381.1995.tb13229.x","article-title":"Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter","volume":"114","author":"Clarke","year":"1995","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB11","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1471-4159.2003.01657.x","article-title":"Neuroprotective effects of prior limb use in 6-hydroxydopamine-treated rats: possible role of GDNF","volume":"85","author":"Cohen","year":"2003","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0006-8993(76)90843-X","article-title":"The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain","volume":"118","author":"Costall","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB13","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1523\/JNEUROSCI.16-16-05216.1996","article-title":"Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP","volume":"16","author":"Emmi","year":"1996","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB14","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1523\/JNEUROSCI.17-10-03840.1997","article-title":"Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1\/D5, but not D2, dopamine receptor antagonists","volume":"17","author":"Emmi","year":"1997","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB15","first-page":"383","article-title":"From laboratory to clinic: noradrenergic enhancement of physical therapy for stroke or trauma patients","volume":"73","author":"Feeney","year":"1997","journal-title":"Adv. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(00)00009-9","article-title":"Axonal sprouting following lesions of the rat substantia nigra","volume":"97","author":"Finkelstein","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB17","article-title":"An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease suitable for evaluating neuroprotective therapies: effects of methylphenidate","author":"Fleming","year":"2003","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s002130000417","article-title":"Basic fibroblast growth factor as a mediator of the effects of glutamate in the development of long lasting sensitization to stimulant drugs: studies in the rat","volume":"151","author":"Flores","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0306-4522(00)00115-9","article-title":"Changes in astrocytic basic fibroblast growth factor expression during and after prolonged exposure to escalating doses of amphetamine","volume":"298","author":"Flores","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB18","doi-asserted-by":"crossref","first-page":"9547","DOI":"10.1523\/JNEUROSCI.18-22-09547.1998","article-title":"Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist","volume":"18","author":"Flores","year":"1998","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/JNEUROSCI.20-02-j0003.2000","article-title":"Requirement of endogenous basic fibroblast growth factor for sensitization to amphetamine","volume":"20","author":"Flores","year":"2000","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00001756-199412300-00044","article-title":"Differentiation of motor inactivation from movement asymmetry effects in an animal model of hemi-parkinsonism","volume":"6","author":"Fornaguera","year":"1994","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB23","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1046\/j.1471-4159.1997.69031322.x","article-title":"Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter","volume":"69","author":"Gainetdinov","year":"1997","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0317167100052173","article-title":"Enhancing recovery after stroke with noradrenergic pharmacology: a new frontier?","volume":"27","author":"Gladstone","year":"2000","journal-title":"Can. J. Neurol. Sci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0028-3908(99)00249-X","article-title":"Effects of amphetamines and small related molecules on recovery after stroke in animals and man","volume":"39","author":"Goldstein","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/(SICI)1096-9861(19971110)388:1<106::AID-CNE7>3.0.CO;2-5","article-title":"Exaggerated astrocyte reactivity after nigrostriatal deafferentiation in the aged rat","volume":"388","author":"Gordon","year":"1997","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-0173(91)90007-U","article-title":"Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity","volume":"16","author":"Kalivas","year":"1991","journal-title":"Brain Res. Rev"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB29","first-page":"1095","article-title":"Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine and cocaine","volume":"245","author":"Kalivas","year":"1988","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(02)02190-8","article-title":"Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment","volume":"451","author":"Kantor","year":"2002","journal-title":"Eur. J. Pharmacol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB31","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00004647-199607000-00003","article-title":"Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat","volume":"16","author":"Kawamata","year":"1996","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB32","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1073\/pnas.94.15.8179","article-title":"Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction","volume":"94","author":"Kawamata","year":"1997","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB34","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1046\/j.1460-9568.2000.00274.x","article-title":"Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor","volume":"12","author":"Kirik","year":"2000","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0006-8993(96)01384-4","article-title":"Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat","volume":"750","author":"Letchworth","year":"1997","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB37","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1523\/JNEUROSCI.21-08-02799.2001","article-title":"Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys","volume":"21","author":"Letchworth","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB38","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/sj.npp.1300115","article-title":"The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen","volume":"28","author":"Li","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB39","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0169-328X(97)00136-8","article-title":"Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration","volume":"49","author":"Lu","year":"1997","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB40","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/BF01273324","article-title":"Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism","volume":"104","author":"Maggio","year":"1997","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB41","doi-asserted-by":"crossref","first-page":"14083","DOI":"10.1073\/pnas.94.25.14083","article-title":"Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats","volume":"94","author":"Mandel","year":"1997","journal-title":"Proc. Natl. Acad. Sci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0006-8993(00)02790-6","article-title":"Neuroprotective signaling and the aging brain: take away my food and let me run","volume":"886","author":"Mattson","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0006-8993(02)03160-8","article-title":"Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration","volume":"949","author":"Meredith","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0165-6147(99)01379-6","article-title":"Dopamine transporters and neuronal injury","volume":"20","author":"Miller","year":"1999","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB45","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0006-8993(94)90529-0","article-title":"The effect of repeated amphetamine treatment on striatal DA transporter and rotation in rats","volume":"668","author":"Mintz","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB46","series-title":"Program No. 885.5.2002 Abstract Viewer\/Itinerary Planner","article-title":"Effects of forced limb use on behavioral outcome and FGF-2-IR after partial unilateral 6-OHDA lesions of the nigrostriatal dopamine neurons","author":"Moroz","year":"2002"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB47","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0306-4522(02)00974-0","article-title":"Effects of sex and hormonal status on astrocytic FGF-2 and TH-immunoreactivity after medial forebrain bundle 6-hydroxydopamine lesions of the midbrain dopamine neurons","volume":"118","author":"Moroz","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0006-8993(02)03103-7","article-title":"Repeated intermittent treatment with amphetamine induces neurite outgrowth in rat pheochromocytoma cells (PC12 cells)","volume":"951","author":"Park","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB49","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF02244248","article-title":"Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats","volume":"103","author":"Paulson","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB50","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0006-8993(89)90597-0","article-title":"A 6-hydroxydopamine-induced selective parkinsonian rat model","volume":"494","author":"Perese","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB52","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00001756-199301000-00010","article-title":"Dopaminergic gene expression during amphetamine withdrawal","volume":"4","author":"Persico","year":"1993","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB53","first-page":"963","article-title":"Withdrawal of repeated intravenous infusions of cocaine persistently reduces binding to dopamine transporters in the nucleus accumbens of Lewis rats","volume":"269","author":"Pilotte","year":"1994","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB54","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1046\/j.1471-4159.1997.69031093.x","article-title":"A multisubstrate kinetic mechanism of dopamine transport in the nucleus accumbens and its inhibition by cocaine","volume":"69","author":"Povlock","year":"1997","journal-title":"J. Neurochem"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB55","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(95)00066-R","article-title":"Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine","volume":"67","author":"Przedborski","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0304-3940(85)90141-7","article-title":"Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum","volume":"59","author":"Ricaurte","year":"1985","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB57","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0173(86)90002-0","article-title":"Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis","volume":"396","author":"Robinson","year":"1986","journal-title":"Brain Res. Rev"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB58","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1523\/JNEUROSCI.17-21-08491.1997","article-title":"Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine","volume":"17","author":"Robinson","year":"1997","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB59","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1046\/j.1460-9568.1999.00576.x","article-title":"Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine","volume":"11","author":"Robinson","year":"1999","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(88)91560-0","article-title":"Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats","volume":"450","author":"Robinson","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB61","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1523\/JNEUROSCI.14-05-02687.1994","article-title":"Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system","volume":"14","author":"Robinson","year":"1994","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB62","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1097\/00001756-199710200-00027","article-title":"Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP","volume":"8","author":"Sanghera","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB63","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0306-4522(94)90605-X","article-title":"Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat","volume":"59","author":"Sauer","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB64","series-title":"Central Nervous System Diseases","first-page":"131","article-title":"Intervention strategies for degeneration of dopamine neurons in Parkinsonism: optimizing behavioral assessment of outcome","author":"Schallert","year":"1999"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(96)00015-9","article-title":"Unilateral 6-hydroxydopamine lesions of the meso-striatal dopamine neurons and their physiological sequelae","volume":"49","author":"Schwarting","year":"1996","journal-title":"Prog. Neurobiol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB66","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB67","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3940(97)00768-4","article-title":"Dopamine transporter mRNA is up-regulated in the substantia nigra and the ventral tegmental area of amphetamine-sensitized rats","volume":"236","author":"Shilling","year":"1997","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB68","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00001756-199601310-00060","article-title":"Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine","volume":"7","author":"Shults","year":"1996","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0006-8993(00)02900-0","article-title":"Fibroblast growth factor-2-producing fibroblasts protect the nigrostriatal dopaminergic system from 6-hydroxydopamine","volume":"883","author":"Shults","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.expneurol.2003.08.017","article-title":"Can the brain be protected through exercise? Lessons from an animal model of parkinsonism","volume":"184","author":"Smith","year":"2003","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB71","first-page":"S182","article-title":"Correlation of cortical plasticity with behavioral recovery following stroke with amphetamine administration","volume":"15","author":"Stroemer","year":"1995","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB72","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/01.STR.29.11.2381","article-title":"Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats","volume":"29","author":"Stroemer","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB73","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1460-9568.1998.00016.x","article-title":"Long-term protection of the rat nigrostriatal dopaminergic system by glial cell line-derived neurotrophic factor against 6-hydroxydopamine in vivo","volume":"10","author":"Sullivan","year":"1998","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB74","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.21-12-04427.2001","article-title":"Forced limb-use effects on the behavioral and neurochemical effects of 6-hydroxydopamine","volume":"21","author":"Tillerson","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB75","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1523\/JNEUROSCI.22-15-06790.2002","article-title":"Forced nonuse in unilateral parkinsonian rats exacerbates injury","volume":"22","author":"Tillerson","year":"2002","journal-title":"J. Neurosci"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB76","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0306-4522(03)00096-4","article-title":"Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson's disease","volume":"119","author":"Tillerson","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB77","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-8993(93)91761-G","article-title":"Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat","volume":"605","author":"Vezina","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.expneurol.2004.05.012_BIB78","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(90)90902-N","article-title":"Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects","volume":"516","author":"Vezina","year":"1990","journal-title":"Brain Res"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604001864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T16:57:00Z","timestamp":1585846620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604001864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0014488604001864"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.05.012","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}